KeMRI faces setback in research following frozen USAID funding

Prof. Feiko Ter Kuile and KEMRI Director General Prof. Elijah Songok (left) address press on 12th February 2025 at Safari Park Hotel in Nairobi. KEMRI DG Songok revealed that US funding cuts have affected 40 % of the institute's programmes, putting approximately 824 staff members at risk of losing their jobs. [Edward Kiplimo, Standard]

In February 2024, the Kenya Medical Research Institute (KeMRI) announced that it had received funding for the search for an HIV vaccine from the United States Agency for International Development (USAID).

This five-year funding was meant to assist African researchers in the quest for an HIV vaccine through preliminary trials.